Gobbetti, Thomas
Berger, Scott B.
Fountain, Kathryn
Slocombe, Tom
Rowles, Alison
Pearse, Gail
Harada, Isobel
Bertin, John
Haynes, Andrea C.
Beal, Allison M.
Article History
Received: 19 December 2019
Revised: 19 March 2020
Accepted: 20 March 2020
First Online: 6 April 2020
Conflict of interest
: The authors declare the following competing financial interest(s): all authors are current stockholders of GlaxoSmithKline. All authors, except for Scott B. Berger, are current employees of GlaxoSmithKline. Scott Berger is currently at Janssen Pharmaceutica.